Epstein-Barr virus-associated monomorphic post-transplant lymphoproliferative disorder after pediatric kidney transplantation: A case report

被引:0
|
作者
Zhen Wang [1 ]
Yang Xu [1 ]
Jie Zhao [1 ]
Ying-Xin Fu [1 ]
机构
[1] Department of Kidney Transplantation, Tianjin First Central Hospital
关键词
D O I
暂无
中图分类号
R726.9 [小儿泌尿科学];
学科分类号
100202 ;
摘要
BACKGROUND Post-transplant lymphoproliferative disease(PTLD) is the most common malignant tumor that occurs after kidney transplantation in children, and is associated with Epstein-Barr virus(EBV).CASE SUMMARY We report a case of PTLD that occurred in a 17-year-old female patient at 5 mo post-transplant. The first symptom was abdominal pain accompanied by fever, nausea, and vomiting. EBV-associated monomorphic PTLD with multiple abdominal nodules was diagnosed by pathology, clinical manifestations, imaging results, and the presence of EB-DNA. After successful treatment with rituximab, the abdominal nodules in the spleen and liver disappeared.CONCLUSION Early pathological biopsy to confirm the diagnosis is critical to treatment and prognosis. Reducing immunosuppression and rituximab therapy are effective methods for treating PTLD, but need to be initiated as early as possible.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 50 条
  • [31] Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation: A Single Institute Experience with Focus on Epstein-Barr Virus Status.
    Zhang, P.
    King, R.
    Ristow, K.
    Cornell, L.
    Cosio, F.
    Habermann, T.
    Alexander, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 755 - 755
  • [32] Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
    Chang, Yeh-Chung
    Young, Rebecca R.
    Mavis, Alisha M.
    Chambers, Eileen T.
    Kirmani, Sonya
    Kelly, Matthew S.
    Kalu, Ibukunoluwa C.
    Smith, Michael J.
    Lugo, Debra J.
    PLOS ONE, 2022, 17 (10):
  • [33] The use of objective case ascertainment to identify risk factors for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder in pediatric liver transplant recipients.
    Guthery, SL
    Heubi, JE
    Bucuvalas, J
    Gross, TG
    Ryckman, FC
    Alonso, MH
    Balistreri, WF
    Hornung, RW
    HEPATOLOGY, 2002, 36 (04) : 662A - 662A
  • [34] Epstein-Barr virus and post-transplant lymphoproliferative disease
    Holmes, RD
    Sokol, RJ
    PEDIATRIC TRANSPLANTATION, 2002, 6 (06) : 456 - 464
  • [35] Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation
    Montone, KT
    Litzky, LA
    Wurster, A
    Kaiser, L
    Bavaria, J
    Kotloff, R
    Palevsky, H
    Pietra, GG
    Tomaszewski, JE
    SURGERY, 1996, 119 (05) : 544 - 551
  • [36] Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
    Hyun, Hyesun
    Park, Eujin
    Cho, Myunghyun
    Min, Sang-Il
    Ha, Jongwon
    Kang, Hyoung Jin
    Shin, Hee Young
    Ha, Il-Soo
    Cheong, Hae Il
    Ahn, Yo Han
    Kang, Hee Gyung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (30)
  • [37] Epstein-Barr virus-associated post-transplant smooth muscle tumours in a kidney transplant patient
    Cobenas, Carlos J.
    Pereyra, Priscila
    Spizzirri, Ana Paula
    Santacruz, Cristina Gauto
    Suarez, Angela del Carmen
    Altamirano, Eugenia
    Perez, Paula
    Tello, Nicolas
    PEDIATRIC NEPHROLOGY, 2025, 40 (02) : 389 - 391
  • [38] Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation
    Lim, Wai H.
    Russ, Graeme R.
    Coates, Patrick Th
    NEPHROLOGY, 2006, 11 (04) : 355 - 366
  • [39] Hemophagocytic Lymphohistiocytosis is a Sign of Poor Outcome in Pediatric Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease after Hematopoietic Stem Cell Transplantation
    Ali, Salah S. A.
    Althubaiti, Sami
    Waespe, Nicolas
    Renzi, Samuele
    Memon, Shahbaz
    Krueger, Joerg
    Schechter, Tal
    Ali, Muhammad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S259 - S260
  • [40] Idiopathic Pulmonary Fibrosis Lung Transplant Recipients are at Increased Risk for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder
    Iasella, C. J.
    Winters, S.
    Kois, A.
    Cho, J.
    Hannan, S. J.
    Koshy, R.
    Moore, C.
    Lendermon, E. A.
    Pilewski, J.
    Morrell, M.
    Sanchez, P. G.
    Kass, D.
    Alder, J. K.
    Nouriea, S. M.
    McDyer, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S382 - S383